Effects of Shenshao Decoction (参芍汤) on the inflammatory response in the aorta of a rat atherosclerotic model
Z Xue, X Shang, S Lv, H Xu, Q Zhang… - Chinese journal of …, 2013 - Springer
… in the occurrence of atherosclerosis and … is a CD4 T cell-derived pro-inflammatory cytokine,
and is known to play an active role in the development of inflammation, autoimmune diseases…
and is known to play an active role in the development of inflammation, autoimmune diseases…
[HTML][HTML] … (乳香Rǔ Xiāng; Boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases
… Atherosclerosis is the building up of plaque inside the blood vessels, causing hardening of
the arteries. It is the major cause of coronary heart disease and … is an autoimmune disease in …
the arteries. It is the major cause of coronary heart disease and … is an autoimmune disease in …
Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A computed tomography angiography study 在2 型 …
… liver disease is associated with significant coronary artery disease in type 2 diabetic patients.
… attenuation and coronary artery atherosclerosis by coronary CT examination is feasible. …
… attenuation and coronary artery atherosclerosis by coronary CT examination is feasible. …
Dipeptidyl peptidase‐4 inhibitors: Multitarget drugs, not only antidiabetes drugs (D ipeptidyl peptidase‐4 抑制剂: 多靶点药物, 不仅仅是降糖药)
Y Zhao, L Yang, Z Zhou - Journal of Diabetes, 2014 - Wiley Online Library
… CD26 is involved in a variety of human autoimmune diseases. Thus, … is associated with
hypercoagulability,78 which leads to atherosclerosis and increased cardiovascular diseases.79 …
hypercoagulability,78 which leads to atherosclerosis and increased cardiovascular diseases.79 …
抗体药物行业领军者的专利布局及抗体药物的研发趋势
付秀峰 - 2019 - ir.lzu.edu.cn
… and autoimmune diseases will continue to gain popularity, while the research and development
of cardiovascular diseases such as hyperglycemia, atherosclerosis, … There is a big gap …
of cardiovascular diseases such as hyperglycemia, atherosclerosis, … There is a big gap …
[HTML][HTML] 系统性红斑狼疮伴动脉粥样硬化危险因素研究进展
崔天晓 - Advances in Clinical Medicine, 2023 - hanspub.org
… is an autoimmune disease with chronic inflammatory tissue damage mediated by autoimmune
… activity in the early stages, while the later stages tend to develop atherosclerosis (AS), …
… activity in the early stages, while the later stages tend to develop atherosclerosis (AS), …
非血管性疾病与动脉粥样硬化: 内皮炎症和氧化应激的关键作用
刘杰 - 中国动脉硬化杂志, 2023 - scholars.cityu.edu.hk
… Atherosclerosis (As) is a focal vascular disease that … diseases, digestive system diseases,
urinary and reproductive system diseases, autoimmune diseases and metabolic diseases from …
urinary and reproductive system diseases, autoimmune diseases and metabolic diseases from …
Correlations of non‐alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults: 肥胖的中国成年人非酒精性脂肪性肝病和 …
Y Liu, C Liu, X Shi, M Lin, B Yan, X Zeng… - Journal of …, 2017 - Wiley Online Library
… atherosclerosis is controversial, with some studies reporting positive7, 8 and others no9
association. This is … used to measure subclinical atherosclerosis, and in subject characteristics. …
association. This is … used to measure subclinical atherosclerosis, and in subject characteristics. …
[PDF][PDF] ISTANBUL TECHNICAL UNIVERSITY 击GRADUATE SCHOOL OF SCIENCE ENGINEERING AND TECHNOLOGY
ÇS ZHMUROV - 2016 - core.ac.uk
… The underlying pathological condition of cardiovascular diseases is atherosclerosis. Although
atherosclerosis is an irreversible process beginning with birth, the diseases it causes can …
atherosclerosis is an irreversible process beginning with birth, the diseases it causes can …
Diagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the S tudy G roup of L iver and M …
X Gao, JG Fan… - Journal of …, 2013 - Wiley Online Library
… of fibrosis is in the range 22%–60%;18 NASH and/or fibrosis is … metabolic diseases suggests
that NAFLD is not a disease … increasingly used as a surrogate marker for atherosclerosis45 …
that NAFLD is not a disease … increasingly used as a surrogate marker for atherosclerosis45 …